leuprolide + testosterone

Leuprolide + testosterone is a hypothetical or investigational combination of two hormones with opposing actions. Leuprolide is a synthetic peptide analog of gonadotropin-releasing hormone (GnRH) and acts as a GnRH receptor superagonist, leading to downregulation of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn suppresses endogenous production of sex steroids such as testosterone and estradiol[1][5]. It is primarily used for androgen deprivation therapy in conditions like prostate cancer, endometriosis, uterine fibroids, and central precocious puberty[1][7]. Testosterone is an androgenic steroid hormone responsible for the development and maintenance of male secondary sexual characteristics. In clinical practice, leuprolide reduces endogenous testosterone levels to treat diseases driven by sex hormones; exogenous administration of testosterone would counteract this effect. There are no approved or widely recognized pharmaceutical products combining both agents simultaneously for therapeutic use.